HilleVax, Inc. (NASDAQ:HLVX – Get Rating)’s share price traded up 6.2% during trading on Friday . The stock traded as high as $16.62 and last traded at $16.62. 4 shares traded hands during mid-day trading, a decline of 100% from the average session volume of 38,379 shares. The stock had previously closed at $15.65.
HilleVax Stock Performance
The company has a quick ratio of 34.77, a current ratio of 34.77 and a debt-to-equity ratio of 0.02. The stock has a fifty day moving average price of $16.63 and a two-hundred day moving average price of $16.26.
HilleVax (NASDAQ:HLVX – Get Rating) last issued its quarterly earnings data on Thursday, November 10th. The company reported ($0.45) earnings per share for the quarter, beating the consensus estimate of ($0.88) by $0.43. Equities research analysts anticipate that HilleVax, Inc. will post -6.93 EPS for the current fiscal year.
Institutional Inflows and Outflows
HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus and related illness. The company was formerly known as MokshaCo, Inc and changed its name to HilleVax, Inc in February 2021.
- Get a free copy of the StockNews.com research report on HilleVax (HLVX)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving ’23 Growth
Receive News & Ratings for HilleVax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HilleVax and related companies with MarketBeat.com's FREE daily email newsletter.